Skip to main content
. 2023 May 12;10:1176710. doi: 10.3389/fcvm.2023.1176710

Figure 2.

Figure 2

Recordings from the wearing time of the wearable cardioverter defibrillator from two different patients. Patient (A) shows a very compliance to the WCD therapy with an average wearing time of 23.91 h per day. Patient (B) shows a low compliance to the WCD therapy with an average wearing time of 16.84 h per day, resulting to early termination of the surveillance and exclusion from the study.